Company intelligence / Profile preview

Medacta

Castel San Pietro, Ticino, Switzerlandmedacta.com ↗

Ownership: Public · MOVE
Employees: ~1300
Development stage: Commercial

Overview

Medacta’s products are commercially available worldwide. The company has over two decades of clinical experience with its core technologies such as the AMIS technique for hip replacement and has demonstrated improved patient outcomes in joint replacement through innovations like kinematic alignment in total knee arthroplasty. Its NextAR platform leverages augmented reality to enhance surgical precision. The company supports its technologies with extensive medical education programs via the M.O.R.E. Institute

Therapeutic areas: OtherRheumatologyNeurology
Modalities: Device
Industry: Implantable Medical Devices

Partnerships

Collaborates closely with surgeons and universities globally through the M.O.R.E. Institute but no specific major pharma/biotech partnerships noted

Beyond the preview

Go deeper on Medacta.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medacta.

Explore the full profile